IDEXX Laboratories, Inc.
IDXX
$528.68
-$5.24-0.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.74% | 14.82% | 17.94% | 44.61% | 3.01% |
| Total Depreciation and Amortization | 10.63% | 14.88% | 7.31% | 11.12% | 13.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 81.97% | 148.13% | 960.37% | 1,458.77% | 50.91% |
| Change in Net Operating Assets | -47.89% | 294.38% | 65.22% | -1,247.37% | 25.46% |
| Cash from Operations | 11.89% | 35.77% | 82.82% | -25.20% | 19.83% |
| Capital Expenditure | -6.52% | -0.61% | -10.77% | -2.39% | 0.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -475.00% | 112.32% | -3,414.94% | 19.10% | 26.44% |
| Cash from Investing | -13.29% | 29.40% | -63.95% | -2.19% | 72.31% |
| Total Debt Issued | 89.93% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 152.48% | 34.81% | 920.22% | 223.20% | -65.55% |
| Repurchase of Common Stock | 11.16% | 3.33% | -8.74% | -57.27% | -146.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 35.99% | -52.80% | -7.67% | 21.22% | -129.27% |
| Foreign Exchange rate Adjustments | 64.93% | 99.75% | -111.05% | 1,500.00% | 42.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.46% | -37.93% | 146.87% | -84.99% | -120.00% |